BioSpace

Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis

Growth portfolio products like Leqembi and Spinraza helped drive Biogen to $2.8 billion in revenue for the third quarter.

By BioSpace

1 min read
Biogen notches 3rd straight quarter of growth thanks to newer products, Apellis
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights